More recently, results in contrast with the previous ones disclosed an increase in BDNF serum levels in COVID-19 patients with neurological disorders accompanied by increased serum inflammation (TNF-α) and oxidative stress indexes (Malondialdehyde) [112]. Here, BDNF is linked to COVID-19.